Efficacy of Intravenous Iron Therapy in Female Patients with Iron Deficiency Anemia

Authors : Sevgi Güneş, Naci Ömer Alayunt, Osman Özüdoğru

Pages : 134-138

Doi:10.46810/tdfd.1342791

View : 151 | Download : 104

Publication Date : 2023-12-28

Article Type : Research Paper

Abstract :Abstract: In this study, it was aimed to show the efficacy of intravenous (IV) ferric carboxymaltose treatment for iron deficiency anemia (IDA), which is a public health problem due to its high prevalence in the world and in Turkey. Since it is the first study in the region, its importance is increasing even more. Eighty female diagnosed with IDA and treated with IV iron carboxymaltose, who applied to Siirt Training and Research Hospital Internal Diseases Polyclinics between June 2018 and September 2019, were included in the study. After obtaining voluntary consent of female patients, biochemical data of pre- and post-treatment were included in the study retrospectively. After treatment, hemoglobin (HGB), hematocrit (HTC), mean cell volume (MCV), ferritin, iron and B12 values increased statistically (p<0.05). In addition, platelet (PLT), total iron binding capacity (TIBC) and folate values were statistically significantly lower (p<0.05). The study is important in terms of revealing the female IDA profile in the region and showing the positive results of IV iron therapy data. It is thought that the study can be a guide in finding solutions to irrational drug use, prolongation of the treatment period and high expenditures while creating IDA treatment protocols.
Keywords : Demir eksikliği anemisi, Demir replasmanı, İntravenoz karboksimaltoz, Serum TIBC, Serum folat

ORIGINAL ARTICLE URL